505 related articles for article (PubMed ID: 33678036)
1. Early intervention with probiotics and metformin alleviates liver injury in NAFLD rats via targeting gut microbiota dysbiosis and p-AKT/mTOR/LC-3II pathways.
Seif El-Din SH; Salem MB; El-Lakkany NM; Hammam OA; Nasr SM; Okasha H; Ahmed LA; Saleh S; Botros SS
Hum Exp Toxicol; 2021 Sep; 40(9):1496-1509. PubMed ID: 33678036
[TBL] [Abstract][Full Text] [Related]
2. Gut microbiota modulation as a promising therapy with metformin in rats with non-alcoholic steatohepatitis: Role of LPS/TLR4 and autophagy pathways.
Ahmed LA; Salem MB; Seif El-Din SH; El-Lakkany NM; Ahmed HO; Nasr SM; Hammam OA; Botros SS; Saleh S
Eur J Pharmacol; 2020 Nov; 887():173461. PubMed ID: 32758573
[TBL] [Abstract][Full Text] [Related]
3. Metformin ameliorates maternal high-fat diet-induced maternal dysbiosis and fetal liver apoptosis.
Huang SW; Ou YC; Tang KS; Yu HR; Huang LT; Tain YL; Lin IC; Sheen JM; Hou CY; Tsai CC; Tiao MM
Lipids Health Dis; 2021 Sep; 20(1):100. PubMed ID: 34496884
[TBL] [Abstract][Full Text] [Related]
4. Lactobacillus reuteri DSM 17938 alleviates d-galactosamine-induced liver failure in rats.
Jiang H; Yan R; Wang K; Wang Q; Chen X; Chen L; Li L; Lv L
Biomed Pharmacother; 2021 Jan; 133():111000. PubMed ID: 33202285
[TBL] [Abstract][Full Text] [Related]
5. Oral Administration of Compound Probiotics Ameliorates HFD-Induced Gut Microbe Dysbiosis and Chronic Metabolic Inflammation via the G Protein-Coupled Receptor 43 in Non-alcoholic Fatty Liver Disease Rats.
Liang Y; Liang S; Zhang Y; Deng Y; He Y; Chen Y; Liu C; Lin C; Yang Q
Probiotics Antimicrob Proteins; 2019 Mar; 11(1):175-185. PubMed ID: 29353414
[TBL] [Abstract][Full Text] [Related]
6. Structural modulation of gut microbiota during alleviation of non-alcoholic fatty liver disease with Gynostemma pentaphyllum in rats.
Shen SH; Zhong TY; Peng C; Fang J; Lv B
BMC Complement Med Ther; 2020 Feb; 20(1):34. PubMed ID: 32024509
[TBL] [Abstract][Full Text] [Related]
7. Protective effect of quercetin on high-fat diet-induced non-alcoholic fatty liver disease in mice is mediated by modulating intestinal microbiota imbalance and related gut-liver axis activation.
Porras D; Nistal E; Martínez-Flórez S; Pisonero-Vaquero S; Olcoz JL; Jover R; González-Gallego J; García-Mediavilla MV; Sánchez-Campos S
Free Radic Biol Med; 2017 Jan; 102():188-202. PubMed ID: 27890642
[TBL] [Abstract][Full Text] [Related]
8. Effects of Maternal Gut Microbiota-Targeted Therapy on the Programming of Nonalcoholic Fatty Liver Disease in Dams and Fetuses, Related to a Prenatal High-Fat Diet.
Yu HR; Sheen JM; Hou CY; Lin IC; Huang LT; Tain YL; Cheng HH; Lai YJ; Lin YJ; Tiao MM; Tsai CC
Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235659
[TBL] [Abstract][Full Text] [Related]
9. Combination of Probiotics and
Wang W; Xu AL; Li ZC; Li Y; Xu SF; Sang HC; Zhi F
Diabetes Metab J; 2020 Apr; 44(2):336-348. PubMed ID: 31950772
[TBL] [Abstract][Full Text] [Related]
10.
Liu T; Zhou L; Li X; Song W; Liu Y; Wu S; Wang P; Dai X; Shi L
J Agric Food Chem; 2024 May; 72(17):9880-9892. PubMed ID: 38646869
[No Abstract] [Full Text] [Related]
11. Selenium-Enriched Probiotic Alleviates Western Diet-Induced Non-alcoholic Fatty Liver Disease in Rats via Modulation of Autophagy Through AMPK/SIRT-1 Pathway.
Pant R; Sharma N; Kabeer SW; Sharma S; Tikoo K
Biol Trace Elem Res; 2023 Mar; 201(3):1344-1357. PubMed ID: 35499800
[TBL] [Abstract][Full Text] [Related]
12. Secretion of Recombinant Interleukin-22 by Engineered Lactobacillus reuteri Reduces Fatty Liver Disease in a Mouse Model of Diet-Induced Obesity.
Oh JH; Schueler KL; Stapleton DS; Alexander LM; Yen CE; Keller MP; Attie AD; van Pijkeren JP
mSphere; 2020 Jun; 5(3):. PubMed ID: 32581074
[TBL] [Abstract][Full Text] [Related]
13. Perilla Seed Oil Alleviates Gut Dysbiosis, Intestinal Inflammation and Metabolic Disturbance in Obese-Insulin-Resistant Rats.
Kangwan N; Pratchayasakul W; Kongkaew A; Pintha K; Chattipakorn N; Chattipakorn SC
Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579018
[TBL] [Abstract][Full Text] [Related]
14. Protective Role of Probiotic Supplements in Hepatic Steatosis: A Rat Model Study.
Azarang A; Farshad O; Ommati MM; Jamshidzadeh A; Heydari R; Abootalebi SN; Gholami A
Biomed Res Int; 2020; 2020():5487659. PubMed ID: 33299871
[TBL] [Abstract][Full Text] [Related]
15. Probiotics Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats via Gut Microbiota/FXR/FGF15 Signaling Pathway.
Luo M; Yan J; Wu L; Wu J; Chen Z; Jiang J; Chen Z; He B
J Immunol Res; 2021; 2021():2264737. PubMed ID: 34458376
[TBL] [Abstract][Full Text] [Related]
16. Ileal Bile Acid Transporter Inhibitor Improves Hepatic Steatosis by Ameliorating Gut Microbiota Dysbiosis in NAFLD Model Mice.
Matsui M; Fukunishi S; Nakano T; Ueno T; Higuchi K; Asai A
mBio; 2021 Aug; 12(4):e0115521. PubMed ID: 34225483
[TBL] [Abstract][Full Text] [Related]
17. The Effect of Probiotics (MCP
Mohamad Nor MH; Ayob N; Mokhtar NM; Raja Ali RA; Tan GC; Wong Z; Shafiee NH; Wong YP; Mustangin M; Nawawi KNM
Nutrients; 2021 Sep; 13(9):. PubMed ID: 34579068
[TBL] [Abstract][Full Text] [Related]
18. Role of Probiotics in Non-alcoholic Fatty Liver Disease: Does Gut Microbiota Matter?
Xie C; Halegoua-DeMarzio D
Nutrients; 2019 Nov; 11(11):. PubMed ID: 31752378
[TBL] [Abstract][Full Text] [Related]
19. Effects of shenling baizhu powder herbal formula on intestinal microbiota in high-fat diet-induced NAFLD rats.
Zhang Y; Tang K; Deng Y; Chen R; Liang S; Xie H; He Y; Chen Y; Yang Q
Biomed Pharmacother; 2018 Jun; 102():1025-1036. PubMed ID: 29710519
[TBL] [Abstract][Full Text] [Related]
20. The Combination of Berberine, Tocotrienols and Coffee Extracts Improves Metabolic Profile and Liver Steatosis by the Modulation of Gut Microbiota and Hepatic miR-122 and miR-34a Expression in Mice.
Cossiga V; Lembo V; Nigro C; Mirra P; Miele C; D'Argenio V; Leone A; Mazzone G; Veneruso I; Guido M; Beguinot F; Caporaso N; Morisco F
Nutrients; 2021 Apr; 13(4):. PubMed ID: 33924725
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]